National Innovation and Science Agenda

National Innovation and Science Agenda
Name	National Innovation and Science Agenda
Country	Australia
Launched	2015
Prime minister	Malcolm Turnbull
Minister	Christopher Pyne
Focus	Innovation, Science, Research, Entrepreneurship

National Innovation and Science Agenda

The National Innovation and Science Agenda was a policy package announced in 2015 under Malcolm Turnbull intended to stimulate innovation and science across Australia through tax measures, research reforms, and industry programs. It sought to connect researchers from institutions such as the Commonwealth Scientific and Industrial Research Organisation, Australian National University, and University of Melbourne with firms including Atlassian, Cochlear Limited, and CSL Limited to boost commercialisation and productivity. The agenda intersected with portfolios managed by figures such as Christopher Pyne, Greg Hunt, and advisors linked to entities like the Business Council of Australia and Australian Research Council.

Background and Rationale

The agenda emerged amid comparisons with innovation strategies in jurisdictions such as the United States, United Kingdom, Germany, Israel, and Singapore, and against reviews like the Industry Innovation and Competitiveness Agenda and reports by the Productivity Commission, Grattan Institute, and Commonwealth Treasury. It responded to perceived challenges identified in audits by the Australian Bureau of Statistics, productivity analyses by OECD and World Economic Forum rankings, and sectoral pressures in areas including mining and manufacturing affected by firms like BHP Billiton and Rio Tinto. Key domestic influences included recommendations from the Chief Scientist of Australia and submissions from universities such as University of Sydney and research institutes like the Walter and Eliza Hall Institute of Medical Research.

Key Policies and Initiatives

Measures combined fiscal instruments, regulatory adjustments, and programmatic support. Tax initiatives referenced reform models from Research and Development Tax Incentive precedents and targeted startups like Aconex and Envato. Programs included investment in incubators and accelerators analogous to Start-Up Chile and partnerships with venture capital firms such as Blackbird Ventures and AirTree Ventures. Research translation efforts linked to the National Health and Medical Research Council, cooperative schemes involving CSIRO and commercial partners, and reforms to grant processes influenced by practices from National Institutes of Health and European Research Council. Intellectual property pathways considered cases like Cochlear Limited and licensing frameworks inspired by Stanford University technology transfer models.

Implementation and Governance

Delivery involved coordination among federal departments, statutory agencies, and advisory bodies including the Australian Research Council, CSIRO, and state governments of New South Wales, Victoria, and Queensland. Oversight mechanisms drew on precedents from the Commonwealth Grants Commission and intergovernmental forums like the Council of Australian Governments. Stakeholder engagement processes included consultations with industry associations such as the Australian Industry Group, Australian Chamber of Commerce and Industry, and peak bodies like the Business Council of Australia. Implementation timelines paralleled policy rollouts witnessed in initiatives like the National Broadband Network and education reforms involving TEQSA and the Tertiary Education Quality and Standards Agency.

Funding and Economic Impact

Budget allocations reflected federal fiscal strategy as outlined in the 2015 Australian federal budget and were scrutinised by commentators from Reserve Bank of Australia, Australian Financial Review, and think tanks including the Lowy Institute and Grattan Institute. Funding streams combined direct grants, tax offsets, and incentives similar to mechanisms used by the Small Business Innovation Research program in the United States and venture schemes akin to those in United Kingdom policy. Economic analyses linked projected returns to productivity trends tracked by Australian Bureau of Statistics and international comparisons produced by OECD and IMF, with sectoral implications for pharmaceutical firms like Pfizer collaborators and technology exporters exemplified by Atlassian.

Reception and Criticism

Reactions ranged across academia, industry, and media outlets such as the Sydney Morning Herald, The Australian Financial Review, and The Guardian (Australia). Supporters included proponents from Blackbird Ventures and executives at Atlassian, while critics included commentators from the Australian Council of Learned Academies, union-aligned voices in Australian Council of Trade Unions, and editorial critiques referencing prior debates over the Research and Development Tax Incentive. Concerns highlighted by institutions like the Australian Medical Association and legal scholars cited issues of scale, measurability, and comparisons with reforms in New Zealand and Canada.

Outcomes and Legacy

The agenda influenced subsequent policy decisions, intersecting with later innovation strategies under leaders such as Scott Morrison and informing institutional changes at organisations like the Australian Research Council and CSIRO. It contributed to growth stories for companies including Atlassian, Aconex, and emerging startups incubated by funds such as Main Sequence Ventures. Long-term evaluations by bodies like the Productivity Commission and universities including Monash University and University of Queensland assessed impacts on commercialisation, workforce composition, and R&D intensity relative to international benchmarks from OECD and World Bank data. The initiative remains a reference point in debates involving ministries, research councils, and industry groups about national competitive positioning and innovation policy.

Category:Australian public policy